Skip to main content
NCBI home page
Gut logoLink to Gut
. 1999 Jun;44(6):770–772. doi: 10.1136/gut.44.6.770

Management of bone disease in patients on long term glucocorticoid therapy

J COMPSTON 1
PMCID: PMC1727521  PMID: 10323872

Full Text

The Full Text of this article is available as a PDF (69.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaron J. E., Francis R. M., Peacock M., Makins N. B. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop Relat Res. 1989 Jun;(243):294–305. [PubMed] [Google Scholar]
  2. Adachi J. D., Bensen W. G., Bianchi F., Cividino A., Pillersdorf S., Sebaldt R. J., Tugwell P., Gordon M., Steele M., Webber C. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol. 1996 Jun;23(6):995–1000. [PubMed] [Google Scholar]
  3. Adachi J. D., Bensen W. G., Brown J., Hanley D., Hodsman A., Josse R., Kendler D. L., Lentle B., Olszynski W., Ste-Marie L. G. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):382–387. doi: 10.1056/NEJM199708073370603. [DOI] [PubMed] [Google Scholar]
  4. Buckley L. M., Leib E. S., Cartularo K. S., Vacek P. M., Cooper S. M. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996 Dec 15;125(12):961–968. doi: 10.7326/0003-4819-125-12-199612150-00004. [DOI] [PubMed] [Google Scholar]
  5. Buckley L. M., Leib E. S., Cartularo K. S., Vacek P. M., Cooper S. M. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol. 1995 Jun;22(6):1055–1059. [PubMed] [Google Scholar]
  6. Compston J. E., Audran M., Avouac B., Bouvenot G., Devogelaer J., Eastell R., Fabris F., Gennari C., Jones E. A., Kaufman J. M. Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis. Calcif Tissue Int. 1996 Nov;59(5):323–327. doi: 10.1007/s002239900134. [DOI] [PubMed] [Google Scholar]
  7. Compston J. E. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther. 1995 Jun;9(3):237–250. doi: 10.1111/j.1365-2036.1995.tb00378.x. [DOI] [PubMed] [Google Scholar]
  8. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995 Jan;54(1):49–52. doi: 10.1136/ard.54.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cosman F., Nieves J., Herbert J., Shen V., Lindsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res. 1994 Jul;9(7):1097–1105. doi: 10.1002/jbmr.5650090718. [DOI] [PubMed] [Google Scholar]
  10. Dempster D. W. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 1989 Apr;4(2):137–141. doi: 10.1002/jbmr.5650040202. [DOI] [PubMed] [Google Scholar]
  11. Eastell R., Reid D. M., Compston J., Cooper C., Fogelman I., Francis R. M., Hosking D. J., Purdie D. W., Ralston S. H., Reeve J. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med. 1998 Oct;244(4):271–292. doi: 10.1046/j.1365-2796.1998.00408.x. [DOI] [PubMed] [Google Scholar]
  12. Gluck O. S., Murphy W. A., Hahn T. J., Hahn B. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum. 1981 Jul;24(7):892–898. doi: 10.1002/art.1780240705. [DOI] [PubMed] [Google Scholar]
  13. Hooyman J. R., Melton L. J., 3rd, Nelson A. M., O'Fallon W. M., Riggs B. L. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum. 1984 Dec;27(12):1353–1361. doi: 10.1002/art.1780271205. [DOI] [PubMed] [Google Scholar]
  14. Ishida Y., Heersche J. N. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res. 1998 Dec;13(12):1822–1826. doi: 10.1359/jbmr.1998.13.12.1822. [DOI] [PubMed] [Google Scholar]
  15. Luengo M., Picado C., Del Rio L., Guañabens N., Montserrat J. M., Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 1991 Nov;46(11):803–806. doi: 10.1136/thx.46.11.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lukert B. P., Johnson B. E., Robinson R. G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res. 1992 Sep;7(9):1063–1069. doi: 10.1002/jbmr.5650070909. [DOI] [PubMed] [Google Scholar]
  17. Löfberg R., Ostergaard Thomsen O., Langholz E., Schiöler R., Danielsson A., Suhr O., Graffner H., Påhlman L., Matzen P., Møller-Petersen J. F. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1994 Dec;8(6):623–629. doi: 10.1111/j.1365-2036.1994.tb00340.x. [DOI] [PubMed] [Google Scholar]
  18. Marystone J. F., Barrett-Connor E. L., Morton D. J. Inhaled and oral corticosteroids: their effects on bone mineral density in older adults. Am J Public Health. 1995 Dec;85(12):1693–1695. doi: 10.2105/ajph.85.12.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Peat I. D., Healy S., Reid D. M., Ralston S. H. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis. 1995 Jan;54(1):66–68. doi: 10.1136/ard.54.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pocock N. A., Eisman J. A., Dunstan C. R., Evans R. A., Thomas D. H., Huq N. L. Recovery from steroid-induced osteoporosis. Ann Intern Med. 1987 Sep;107(3):319–323. doi: 10.7326/0003-4819-107-2-319. [DOI] [PubMed] [Google Scholar]
  21. Reid I. R., Wattie D. J., Evans M. C., Stapleton J. P. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med. 1996 Jun 10;156(11):1173–1177. [PubMed] [Google Scholar]
  22. Saag K. G., Emkey R., Schnitzer T. J., Brown J. P., Hawkins F., Goemaere S., Thamsborg G., Liberman U. A., Delmas P. D., Malice M. P. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998 Jul 30;339(5):292–299. doi: 10.1056/NEJM199807303390502. [DOI] [PubMed] [Google Scholar]
  23. Sambrook P. N., Eisman J. A., Yeates M. G., Pocock N. A., Eberl S., Champion G. D. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis. 1986 Nov;45(11):950–953. doi: 10.1136/ard.45.11.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sambrook P., Birmingham J., Kelly P., Kempler S., Nguyen T., Pocock N., Eisman J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993 Jun 17;328(24):1747–1752. doi: 10.1056/NEJM199306173282404. [DOI] [PubMed] [Google Scholar]
  25. Sambrook P., Birmingham J., Kempler S., Kelly P., Eberl S., Pocock N., Yeates M., Eisman J. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990 Dec;5(12):1211–1216. doi: 10.1002/jbmr.5650051204. [DOI] [PubMed] [Google Scholar]
  26. Struys A., Snelder A. A., Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med. 1995 Sep;99(3):235–242. doi: 10.1016/s0002-9343(99)80154-5. [DOI] [PubMed] [Google Scholar]
  27. Walsh L. J., Wong C. A., Pringle M., Tattersfield A. E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996 Aug 10;313(7053):344–346. doi: 10.1136/bmj.313.7053.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. de Groen P. C., Lubbe D. F., Hirsch L. J., Daifotis A., Stephenson W., Freedholm D., Pryor-Tillotson S., Seleznick M. J., Pinkas H., Wang K. K. Esophagitis associated with the use of alendronate. N Engl J Med. 1996 Oct 3;335(14):1016–1021. doi: 10.1056/NEJM199610033351403. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES